The Biden administration has abandoned the prior administration’s defense of the public charge rule, dismissing appeals to the Supreme Court and circuit courts that sought to overturn district court decisions enjoining enforcement of the rule. 

The public charge rule made immigrants that used certain public-benefits programs, including Medicaid, ineligible for visas or permanent U.S. residency. The administration’s decision to dismiss the appeals leaves in place the district court injunctions preventing the rule from taking effect. 

The AHA, joined by America’s Essential Hospitals, the Association of American Medical Colleges, Catholic Health Association of the United States, Children’s Hospital Association, and Federation of American Hospitals, supported challenges to the public charge rule in the 9th Circuit and in California and Washington district courts, explaining that the rule would deter immigrants from seeking health care to which they are entitled and would harm the health of patients and the hospitals that serve them.

The final rule is currently under review by the new administration and expected to be officially withdrawn.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program…
Headline
One in five Medicaid enrollees have been disenrolled since continuous coverage ended last March, a quarter of whom remain uninsured, according to a poll…
Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…